华丰科技
Search documents
华丰科技(688629) - 关于首次公开发行部分战略配售限售股上市流通的公告
2025-06-19 09:47
四川华丰科技股份有限公司 证券代码:688629 证券简称:华丰科技 公告编号:2025-021 关于首次公开发行部分战略配售限售股上市流通的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 本次股票上市类型为首发战略配售股份(限售期 24 月);股票认购方式 为网下,上市股数为3,457,446股。本公司确认,上市流通数量等于该限售期的全 部战略配售股份数量。 本次股票上市流通总数为3,457,446股。 本次股票上市流通日期为2025 年 6 月 27 日。 一、本次上市流通的限售股类型 二、本次上市流通的限售股形成后至今公司股本数量变化情况 根据中国证券监督管理委员会于 2023 年 4 月 23 日出具的《关于同意四川华 丰科技股份有限公司首次公开发行股票注册的批复》(证监许可[2023]893 号),四 川华丰科技股份有限公司(以下简称"公司"或"华丰科技")首次公开发行人民 币普通股(A 股)6,914.8924 万股,并于 2023 年 6 月 27 日在上海证券交易所科创 板上市。公司首 ...
华丰科技(688629) - 申万宏源证券承销保荐有限责任公司关于四川华丰科技股份有限公司首次公开发行部分战略配售限售股上市流通的核查意见
2025-06-19 09:46
申万宏源证券承销保荐有限责任公司 关于四川华丰科技股份有限公司 首次公开发行部分战略配售限售股上市流通的核查意见 申万宏源证券承销保荐有限责任公司(以下简称"申万宏源"或"保荐机构") 作为四川华丰科技股份有限公司(以下简称"华丰科技"或"公司")的保荐机构, 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》 《科创板上市公司持续监管办法(试行)》《上海证券交易所科创板上市公司自律监 管指引第 1 号——规范运作》等有关规定,对华丰科技首次公开发行部分战略配售限 售股上市流通进行了专项核查,并出具核查意见如下: 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 4 月 23 日出具的《关于同意四川华丰科 技股份有限公司首次公开发行股票注册的批复》(证监许可[2023]893 号),公司首次 公开发行人民币普通股(A 股)6,914.8924 万股,并于 2023 年 6 月 27 日在上海证券 交易所科创板上市。公司首次公开发行完成后总股本为 46,099.2831 万股,其中有限售 条件流通股 40,624.2730 万股,无限售条件流通股 5,475.010 ...
华丰科技(688629) - 申万宏源证券承销保荐有限责任公司关于四川华丰科技股份有限公司部分募集资金投资项目结项并将节余募集资金永久补充流动资金及部分募集资金投资项目延期的核查意见
2025-06-19 09:46
申万宏源证券承销保荐有限责任公司 关于四川华丰科技股份有限公司 部分募集资金投资项目结项并将节余募集资金永久补充流动资 金及部分募集资金投资项目延期的核查意见 申万宏源证券承销保荐有限责任公司(以下简称"申万宏源"或"保荐机构") 作为四川华丰科技股份有限公司(以下简称"华丰科技"或"公司")的保荐机构和 主承销商,根据《证券发行上市保荐业务管理办法》《上市公司募集资金监管规则》 《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》《上海证券交 易所科创板股票上市规则》《科创板上市公司持续监管办法(试行)》等有关规定, 对华丰科技部分募集资金投资项目结项并将节余募集资金永久补充流动资金及部分募 集资金投资项目延期进行了审慎核查,核查意见如下: 一、募集资金基本情况 (一)募集资金金额及资金到账情况 经上海证券交易所审核同意,并根据中国证券监督管理委员会出具的《关于同意 四川华丰科技股份有限公司首次公开发行股票注册的批复》(证监许可〔2023〕893 号),公司首次公开发行人民币普通股(A股)69,148,924股,每股发行价格9.26元, 募集资金总额为640,319,036.24元,坐扣承销和保荐 ...
天风证券晨会集萃-20250616
Tianfeng Securities· 2025-06-15 23:42
Group 1 - The report highlights a decline in the AH premium from 144.6 in January 2025 to 128 in June 2025, primarily due to the performance of old economy sectors in Hong Kong outperforming their A-share counterparts [3][38] - It suggests that the decline in AH premium is not due to unique assets in Hong Kong but rather the performance of traditional sectors like resources and finance, which have seen higher increases in Hong Kong [36][38] - The report indicates that the core assets in A-shares have shown relative weakness, while companies like Ningde Times, BYD, and China Merchants Bank have exhibited premiums in Hong Kong compared to A-shares [3][38] Group 2 - The macroeconomic environment shows a recovery in manufacturing, with the PMI rising in May, although it remains in a contraction zone [4] - Social financing increased by 2.29 trillion yuan in May, which is 227.1 billion yuan more than the same period last year, indicating a mixed structure in financing sources [4] - The report notes that the recent interest rate cuts and reserve requirement ratio reductions have led to a rebound in M1, while M2 has decreased, reflecting a tightening of excess liquidity [4] Group 3 - The report emphasizes the importance of innovation in the pharmaceutical sector, particularly with the upcoming adjustments to the basic medical insurance and commercial insurance directories, which are expected to favor innovative drugs [10][22] - It highlights that the recent meeting by the State Council regarding drug procurement policies marks a significant step towards optimizing the procurement process, which could positively impact the revenue and profits of generic drug companies [10][22] - The report recommends focusing on innovative drugs as a core investment strategy, given the expected policy support and market potential [10][22] Group 4 - The report discusses the performance of the stock market, noting that the Shanghai Composite Index closed at 3377, down 0.75%, while the Hang Seng Index closed at 23892.56, down 0.59% [8][15] - It indicates that the market is currently in a volatile phase, with a neutral position recommended for investors due to increased macroeconomic uncertainties [6][10] - The report suggests that sectors such as innovative pharmaceuticals, new consumption, and non-bank financials are recommended for mid-term investment [6][10]
用集群计算帮助国产芯片破局,任正非再度强调AI重要性
Xuan Gu Bao· 2025-06-10 23:30
Group 1 - Ren Zhengfei stated that China has opportunities in mid-to-low-end chips, with numerous domestic chip companies making efforts [1] - The transition to large model era is driving the demand for enhanced interconnectivity between computing cards, leading to an upward trend in domestic computing power construction [1] - Dell'Oro Group predicts that by 2025, the adoption rate of 800G switch ports is expected to exceed 400G data center switch ports, accounting for over 25% of data center switch ports [1] Group 2 - The global sales volume of CPO switches is projected to grow from 50,000 ports in 2023 to 4.5 million ports by 2027 [2] - OCS all-optical network switches are expected to address bandwidth latency and dynamic topology issues in large cluster training across cabinets and regions [2] Group 3 - Leading companies in the switch sector include Ruijie Networks and Fenghuo Communication [3] - Key players in the copper cable market are Huafeng Technology and Wolong Nuclear Materials [3] - Notable companies in the optical module sector include Zhongji Xuchuang, Xinyi Sheng, and Tianfu Communication [3]
铜缆高速连接概念涨3.21%,主力资金净流入这些股
Zheng Quan Shi Bao Wang· 2025-06-05 09:06
今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅(%) | 概念 | 今日涨跌幅(%) | | --- | --- | --- | --- | | 兵装重组概念 | 8.24 | 乳业 | -2.18 | | 共封装光学(CPO) | 3.62 | 动物疫苗 | -2.12 | | 足球概念 | 3.38 | 中韩自贸区 | -2.08 | | 电力物联网 | 3.28 | 猪肉 | -1.76 | | MLOps概念 | 3.27 | 减肥药 | -1.74 | | AI PC | 3.27 | 培育钻石 | -1.69 | | 铜缆高速连接 | 3.21 | CRO概念 | -1.68 | | F5G概念 | 3.15 | 养鸡 | -1.68 | | 中国AI 50 | 3.12 | 仿制药一致性评价 | -1.68 | | AI手机 | 3.02 | 预制菜 | -1.65 | 资金面上看,今日铜缆高速连接概念板块获主力资金净流入12.61亿元,其中,27股获主力资金净流 入,7股主力资金净流入超5000万元,净流入资金居首的是沃尔核材,今日主力资金净流入4.14亿元, 净流入资金居前的还有立讯精密 ...
科创板跟投2025年5月报告 | 5月券商跟投浮亏比例创年内新低,科创板ETF规模超越A500ETF
Mei Ri Jing Ji Xin Wen· 2025-06-05 08:59
Core Insights - As of May 30, 2025, there are 61 companies on the STAR Market with unexpired lock-up periods for sponsor institutions, of which 24 have reported floating losses, resulting in a floating loss ratio of 39.3%, marking a decrease of nearly 3 percentage points from the end of April, the lowest level this year [1][2] - The STAR Market ETF has seen significant inflows, reaching a scale of 205.8 billion yuan, surpassing the A500 ETF at 204.3 billion yuan, making it the second-largest broad-based ETF [1][8] Group 1: Floating Losses and Gains - The floating loss ratio for sponsor institutions has decreased from 41% at the end of February and 74% in August of the previous year, indicating a recovery trend in the market [2] - Seven STAR Market companies have floating gains exceeding 100 million yuan, with 中邮科技 (China Post Technology) leading with a floating gain of 177 million yuan, significantly impacting the performance of its sponsoring institutions [5][6] - The ratio of floating gains to investment amounts for 19 STAR Market projects has exceeded 1, with notable companies like 中邮科技, 华丰科技 (Huafeng Technology), and 先锋精科 (Pioneer Precision) showing ratios above 3 [6] Group 2: Market Performance and ETF Growth - Despite a decline in the STAR Market indices in May, individual stocks showed mixed performance, with some stocks like 爱科赛博 (Aikesaibo) and 佳驰科技 (Jiachi Technology) rising over 20% [7] - The STAR Market ETF has grown by 16% since the beginning of the year, reflecting strong market performance, while other ETFs like A500 and创业板 (ChiNext) have seen declines [8] - The STAR Market's strong performance is correlated with increased capital inflows through ETFs, indicating a positive market sentiment [8]
近一周机构调研多只牛股
news flash· 2025-05-31 04:46
近一周机构调研个股数量有530多只,拓荆科技获调研机构数最多。拓荆科技获179家机构调研。此外, 还有金帝股份(603270)、华丰科技、科兴制药、聚辰股份等个股近一周获较多机构调研;其中科兴制 药等个股属于近期火爆的创新药板块。(人民财讯) ...
创新药板块领涨,20位基金经理发生任职变动
Sou Hu Cai Jing· 2025-05-30 09:11
Market Overview - On May 30, the three major A-share indices collectively declined, with the Shanghai Composite Index falling by 0.47% to 3347.49 points, the Shenzhen Component Index down by 0.85% to 10040.63 points, and the ChiNext Index decreasing by 0.96% to 1993.19 points [1]. Fund Manager Changes - In the past 30 days (April 30 to May 30), a total of 513 fund managers have left their positions across various funds. On May 30 alone, 39 funds announced changes in fund managers, with 6 leaving due to job changes and 2 due to personal reasons [1]. - Notable fund managers who left include those managing a total of 15 funds and 24 funds respectively, indicating significant turnover that could impact fund performance [1]. New Fund Managers - New fund managers have taken over several funds, including Yan Peixian at China Europe Fund, managing assets totaling 12.365 billion yuan, with a notable return of 87.82% over 10 years and 49 days on the China Europe Pure Bond One Year A fund [3]. - Other new appointments include managers for the China Europe Xingyue Bond A and C funds, as well as the China Europe Xingying One Year Open Bond Initiation fund [3]. Fund Research Activity - In the last month, Huaxia Fund conducted the most company research, engaging with 67 listed companies, followed by Bosera Fund with 62 and Harvest Fund with 60 [5]. - The most researched industry was specialized equipment, with 278 instances of fund company inquiries, followed by the medical device sector with 210 inquiries [5]. Individual Stock Research - The most researched stock in the past month was Zhaowei Electromechanical, with 88 fund management companies participating in the research, followed by Anji Technology and Heng'erda with 82 and 80 respectively [6]. - In the past week (May 23 to May 30), Huafeng Technology led with 33 fund institutions conducting research, followed by Jucheng Co., Kexing Pharmaceutical, and Aisen Co. with 27, 24, and 17 respectively [6].
【私募调研记录】益和源资产调研华丰科技
Zheng Quan Zhi Xing· 2025-05-30 00:13
Group 1 - The core viewpoint of the article highlights that Huafeng Technology has seen a year-on-year increase in defense orders during February and March, with expectations for gradual performance improvement in the second and third quarters [1] - The company is facing some price pressure in the defense sector, but the overall impact is manageable, and measures are being taken to reduce costs and increase efficiency [1] - Huafeng Technology has established a project team for humanoid robot connectors, which is still in the incubation stage, indicating a focus on innovation and new product development [1] Group 2 - The company’s defense-related connector products are highly customized for special scenarios, such as environmental resistance and electromagnetic interference [1] - In the electric vehicle sector, Huafeng Technology has clients including SAIC-GM-Wuling and BYD, indicating a strong presence in the growing EV market [1] - The company anticipates a high expense ratio in 2024 due to ongoing product research and development, as well as customer development efforts [1] Group 3 - The high-speed line module products are customized based on client needs, showcasing the company's adaptability and client-focused approach [1] - Huafeng Technology is advancing projects in high-speed backplane connectors and line modules with clients such as Inspur and ZTE [1] - The CPU socket business is still in the investment phase, with expectations to gradually ramp up production starting in 2026 [1]